3-MATIDA
Tocris Bioscience, part of Bio-Techne | Catalog # 2196
Potent and selective mGlu1 antagonist
Discontinued Product
2196 has been discontinued.
View all Group I mGluR Antagonists products.
Key Product Details
Description
Potent and selective mGlu1 antagonist
Product Description
Potent metabotropic glutamate mGlu1 receptor antagonist (IC50 = 6.3 μM at rat mGlu1a). Displays ≥ 40-fold selectivity over other receptors: mGlu5, mGlu2, mGlu4a (IC50 > 300 μM), NMDA and AMPA (IC50 = 250 μM). Neuroprotective in cultured murine cortical cells and rat hippocampal slice cultures in vitro. Reduces the volume of ischemia-induced brain infarcts in rats following systemic administration in vivo.Product Specifications
Molecular Weight
215.23
Formula
C8H9NO4S
Storage
Store at +4°C
Purity
≥99% (HPLC)
Chemical Name
α-Amino-5-carboxy-3-methyl-2-thiopheneacetic acid
CAS Number
518357-51-2
PubChem ID
10398360
InChI Key
KOMWRBFEDDEWEP-UHFFFAOYSA-N
SMILES
CC1=C(SC(=C1)C(O)=O)C(N)C(O)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 10.76 | 50 | |
| 1eq. NaOH | 21.52 | 100 |
Preparing Stock Solutions
for 3-MATIDA
The following data is based on the product molecular weight 215.23
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 4.65 mL | 23.23 mL | 46.46 mL |
| 5 mM | 0.93 mL | 4.65 mL | 9.29 mL |
| 10 mM | 0.46 mL | 2.32 mL | 4.65 mL |
| 50 mM | 0.09 mL | 0.46 mL | 0.93 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Cozzi Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity? Neuropharmacology 2002 PMID: 12213266
- Constantino Stereoselective synthesis and preliminary evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonist. Il Farmaco 2004 PMID: 14871500
- Moroni The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology 2002 PMID: 12015200
Product Specific Notices for 3-MATIDA
For research use only
Loading...
Loading...